Ledger.Open graph →
SEC Form D · filed December 14, 2017

Koligo Therapeutics Inc

Offering
$5K
Sold
$5K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Louisville, KY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

David B. Blanford · Louisville, KYDirectorStuart B. Williams · Louisville, KYDirectorBalamurugan B. Appakalai · Louisville, KYDirectorMichael B. Hughes · Louisville, KYDirectorMatthew B. Lehman · Louisville, KYExec · DirectorJennifer K. Ciresi · San Francisco, CAExec · DirectorAnders N. Utter · Newton, MADirectorDana E. Schmidt · San Francisco, CADirectorDavid Platt · Newton, MADirectorMichel A. Del Buono · San Francisco, CADirectorBrian R. Gaister · BETHESDA, MDExec · DirectorJames Donnelly · Austin, TXDirectorLeslie E. Ross · New York, NYDirectorNobi Kambe · Fremont, CADirectorUmesh Padval · Fremont, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗